While the trial found that ipamorelin did not improve measured outcomes (time to first tolerated meal and first bowel movement) better than a placebo [6], the data indicated that it may help patients recover faster following open laparotomy [7]
The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial
CJC-1295 and ipamorelin are not registered therapeutic goods in Australia, and growth-hormone-releasing peptides are subject to specific regulatory oversight by the Therapeutic Goods Administration
Dihexa and HGF/c-Met: McCoy and colleagues at WSU published animal data showing Dihexa promotes synaptogenesis via the HGF/c-Met pathway at concentrations orders of magnitude lower than BDNF in hippocampal neuron cultures
The growth curve was plotted as shown in Figure 1(A)
Nevertheless, significant challenges remain in the early diagnosis of CHE in elderly patients and in demonstrating that treatment can effectively reduce risks related to quality-of-life impairment, driving performance, and falls